While the U.S. Food & Drug Administration (FDA) is busy targeting ingredients like Red 40 and high fructose corn syrup in soft drinks, it continues to ignore a far more dangerous threat: Chemical Abortion Pills. 

These pills don’t just pose a health risk—they end lives. They kill preborn children and can cause serious harm to the mothers who take them. Despite these dangers, the FDA recently approved a generic version of Mifepristone, one of the two drugs used in chemical abortions. This move has sparked renewed criticism from pro-life advocates, including Students for Life of America’s (SFLA) Vice President of Media & Policy, Kristi Hamrick. 

In her latest op-ed for The Federalist, Hamrick exposes the FDA’s ongoing inaction and highlights the pro-life movement’s relentless efforts to hold the agency accountable. 

“Pro-life advocates have long argued in citizen petitions to the FDA and in court that the deadly drugs expose women to injury, infertility, and death; empower abusers to act against mothers without their knowledge and consent; and create unmonitored abortion water pollution, the chemically tainted blood and placenta tissue, along with human remains, that are flushed into America’s waterways. If you believe the Planned Parenthood-founded Guttmacher Institute about the current volume of chemical abortions, more than 50 tons of pathological medical waste, the EPA term for the remains, pollutes our water every year.” 

Hamrick also critiques the Trump administration’s framing of the issue as merely a labeling problem, warning that this misses the broader threat. 

“So far, some in the Trump administration have talked about mifepristone as though this is a labeling issue, apparently ignoring chemical abortion pill pushers reaching illegally from blue states into red states. But bad paperwork isn’t the core problem, and does anyone really believe that criminal enterprises set up to violate pro-life laws are worried about a product insert?” 

The FDA’s failure to act decisively on Chemical Abortion Pills, despite mounting evidence of harm, raises serious questions about its priorities—and the consequences of its complacency. 

READ THE FULL OP-ED HERE